• Advanced melanoma
• Non-small cell lung cancer
• Classical Hodgkin lymphoma
• Urothelial carcinoma
• Gastric cancer
• Head and neck squamous cell carcinoma
• Cervical cancer
• Primary mediastinal large B-cell lymphoma

The therapeutic effect of Keytruda 100mg Injection is the activation of the immune system to identify and attack cancer cells in the body. It is a type of immunotherapy drug that blocks a protein called PD-1 present in immune cells, which allows the immune system to identify and attack cancer cells more effectively. By doing so, this drug can help slow or inhibit the spread and growth of cancer cells in the body.

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Keytruda 100mg Injection and reduce effectiveness by causing undesirable side effects.

• Keytruda 100mg Injection should be kept refrigerated between 2°C and 8°C (36°F to 46°F).
• This medication should be protected from light and kept in its original packaging until the time of use.
• Keep it out of reach from children and pets.

Keytruda infusion 100mg Injection is a medication that is administered by a healthcare professional, typically in a hospital or clinic setting. The medication is given as an intravenous (IV) infusion. The dosage and frequency will depend on the type and stage of the cancer, as well as the patient’s overall health and response to the medication. The medication is typically given every three to four weeks, and the number of treatment cycles varies with the type and staging of cancer and the patient’s response to the drug. During the infusion, the patient will be monitored by a healthcare professional for any potential side effects or reactions to the medication.